Early use of methylene blue in vasoplegic syndrome: a 10-year propensity score matched cohort study

Background: Vasoplegic syndrome is associated with increased morbidity and mortality in patients undergoing cardiac surgery. This retrospective, single-center study aimed to evaluate the effect of early use of methylene blue (MB) on hemodynamics after an intraoperative diagnosis of vasoplegic syndro...

Full description

Saved in:
Bibliographic Details
Main Authors: Kofler, Othmar (Author) , Simbeck, Maximilian (Author) , Tomasi, Roland (Author) , Hinske, Ludwig Christian Giuseppe (Author) , Klotz, Laura Valentina (Author) , Uhle, Florian (Author) , Born, Frank (Author) , Pichlmaier, Maximilian (Author) , Hagl, Christian Matthias (Author) , Weigand, Markus A. (Author) , Zwißler, Bernhard (Author) , Dossow, Vera von (Author)
Format: Article (Journal)
Language:English
Published: 20 February 2022
In: Journal of Clinical Medicine
Year: 2022, Volume: 11, Issue: 4, Pages: 1-12
ISSN:2077-0383
DOI:10.3390/jcm11041121
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/jcm11041121
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2077-0383/11/4/1121
Get full text
Author Notes:Othmar Kofler, Maximilian Simbeck, Roland Tomasi, Ludwig Christian Hinske, Laura Valentina Klotz, Florian Uhle, Frank Born, Maximilian Pichlmaier, Christian Hagl, Markus Alexander Weigand, Bernhard Zwißler and Vera von Dossow

MARC

LEADER 00000caa a2200000 c 4500
001 1797412035
003 DE-627
005 20220820160109.0
007 cr uuu---uuuuu
008 220404s2022 xx |||||o 00| ||eng c
024 7 |a 10.3390/jcm11041121  |2 doi 
035 |a (DE-627)1797412035 
035 |a (DE-599)KXP1797412035 
035 |a (OCoLC)1341458432 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kofler, Othmar  |e VerfasserIn  |0 (DE-588)1254805737  |0 (DE-627)1797546228  |4 aut 
245 1 0 |a Early use of methylene blue in vasoplegic syndrome  |b a 10-year propensity score matched cohort study  |c Othmar Kofler, Maximilian Simbeck, Roland Tomasi, Ludwig Christian Hinske, Laura Valentina Klotz, Florian Uhle, Frank Born, Maximilian Pichlmaier, Christian Hagl, Markus Alexander Weigand, Bernhard Zwißler and Vera von Dossow 
264 1 |c 20 February 2022 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.04.2022 
520 |a Background: Vasoplegic syndrome is associated with increased morbidity and mortality in patients undergoing cardiac surgery. This retrospective, single-center study aimed to evaluate the effect of early use of methylene blue (MB) on hemodynamics after an intraoperative diagnosis of vasoplegic syndrome (VS). Methods: Over a 10-year period, all patients diagnosed with intraoperative VS (hypotension despite treatment with norepinephrine ≥0.3 μg/kg/min and vasopressin ≥1 IE/h) while undergoing heart surgery and cardiopulmonary bypass were identified, and their data were examined. The intervention group received MB (2 mg/kg intravenous) within 15 min after the diagnosis of vasoplegia, while the control group received standard therapy. The two groups were matched using propensity scores. Results: Of the 1022 patients identified with VS, 221 received MB intraoperatively, and among them, 60 patients received MB within 15 min after the diagnosis of VS. After early MB application, mean arterial pressure was significantly higher, and vasopressor support was significantly lower within the first hour (p = 0.015) after the diagnosis of vasoplegia, resulting in a lower cumulative amount of norepinephrine (p = 0.018) and vasopressin (p = 0.003). The intraoperative need of fresh frozen plasma in the intervention group was lower compared to the control group (p = 0.015). Additionally, the intervention group had higher creatinine values in the first three postoperative days (p = 0.036) without changes in dialysis incidence. The 90-day survival did not differ significantly (p = 0.270). Conclusion: Our results indicate the additive effects of MB use during VS compared to standard vasopressor therapy only. Early MB administration for VS may significantly improve the patients’ hemodynamics with minor side effects. 
650 4 |a cardiac anesthesia 
650 4 |a cardiac surgery 
650 4 |a cardiopulmonary bypass 
650 4 |a methylene blue 
650 4 |a shock 
650 4 |a vasoplegia 
650 4 |a vasoplegic syndrome 
650 4 |a vasopressin 
700 1 |a Simbeck, Maximilian  |e VerfasserIn  |4 aut 
700 1 |a Tomasi, Roland  |d 1981-  |e VerfasserIn  |0 (DE-588)1072381168  |0 (DE-627)82735343X  |0 (DE-576)433792388  |4 aut 
700 1 |a Hinske, Ludwig Christian Giuseppe  |d 1979-  |e VerfasserIn  |0 (DE-588)143890409  |0 (DE-627)655897925  |0 (DE-576)339547235  |4 aut 
700 1 |a Klotz, Laura Valentina  |d 1983-  |e VerfasserIn  |0 (DE-588)143075101  |0 (DE-627)641874685  |0 (DE-576)334894921  |4 aut 
700 1 |a Uhle, Florian  |e VerfasserIn  |0 (DE-588)106860560X  |0 (DE-627)820511730  |0 (DE-576)427922534  |4 aut 
700 1 |a Born, Frank  |d 1961-2022  |e VerfasserIn  |0 (DE-588)1126265756  |0 (DE-627)880860510  |0 (DE-576)484442740  |4 aut 
700 1 |a Pichlmaier, Maximilian  |e VerfasserIn  |0 (DE-588)114405328  |0 (DE-627)729044467  |0 (DE-576)37318557X  |4 aut 
700 1 |a Hagl, Christian Matthias  |d 1967-  |e VerfasserIn  |0 (DE-588)115596879  |0 (DE-627)077352270  |0 (DE-576)289969514  |4 aut 
700 1 |a Weigand, Markus A.  |d 1967-  |e VerfasserIn  |0 (DE-588)1064970435  |0 (DE-627)815375239  |0 (DE-576)424658666  |4 aut 
700 1 |a Zwißler, Bernhard  |d 1960-  |e VerfasserIn  |0 (DE-588)1189692856  |0 (DE-627)166831651X  |4 aut 
700 1 |a Dossow, Vera von  |d 1971-  |e VerfasserIn  |0 (DE-588)123220289  |0 (DE-627)706214390  |0 (DE-576)293610649  |4 aut 
773 0 8 |i Enthalten in  |t Journal of Clinical Medicine  |d Basel : MDPI, 2012  |g 11(2022), 4, Artikel-ID 1121, Seite 1-12  |h Online-Ressource  |w (DE-627)718632478  |w (DE-600)2662592-1  |w (DE-576)365782718  |x 2077-0383  |7 nnas  |a Early use of methylene blue in vasoplegic syndrome a 10-year propensity score matched cohort study 
773 1 8 |g volume:11  |g year:2022  |g number:4  |g elocationid:1121  |g pages:1-12  |g extent:12  |a Early use of methylene blue in vasoplegic syndrome a 10-year propensity score matched cohort study 
856 4 0 |u https://doi.org/10.3390/jcm11041121  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2077-0383/11/4/1121  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220404 
993 |a Article 
994 |a 2022 
998 |g 1064970435  |a Weigand, Markus A.  |m 1064970435:Weigand, Markus A.  |d 910000  |d 910300  |e 910000PW1064970435  |e 910300PW1064970435  |k 0/910000/  |k 1/910000/910300/  |p 10 
998 |g 106860560X  |a Uhle, Florian  |m 106860560X:Uhle, Florian  |d 910000  |d 910300  |e 910000PU106860560X  |e 910300PU106860560X  |k 0/910000/  |k 1/910000/910300/  |p 6 
998 |g 143075101  |a Klotz, Laura Valentina  |m 143075101:Klotz, Laura Valentina  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PK143075101  |e 950000PK143075101  |e 950900PK143075101  |e 50000PK143075101  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 5 
998 |g 1254805737  |a Kofler, Othmar  |m 1254805737:Kofler, Othmar  |d 910000  |d 910300  |e 910000PK1254805737  |e 910300PK1254805737  |k 0/910000/  |k 1/910000/910300/  |p 1  |x j 
999 |a KXP-PPN1797412035  |e 4111726496 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"family":"Kofler","given":"Othmar","role":"aut","display":"Kofler, Othmar"},{"given":"Maximilian","family":"Simbeck","role":"aut","display":"Simbeck, Maximilian"},{"display":"Tomasi, Roland","role":"aut","family":"Tomasi","given":"Roland"},{"given":"Ludwig Christian Giuseppe","family":"Hinske","display":"Hinske, Ludwig Christian Giuseppe","role":"aut"},{"role":"aut","display":"Klotz, Laura Valentina","given":"Laura Valentina","family":"Klotz"},{"display":"Uhle, Florian","role":"aut","family":"Uhle","given":"Florian"},{"given":"Frank","family":"Born","display":"Born, Frank","role":"aut"},{"display":"Pichlmaier, Maximilian","role":"aut","given":"Maximilian","family":"Pichlmaier"},{"family":"Hagl","given":"Christian Matthias","role":"aut","display":"Hagl, Christian Matthias"},{"family":"Weigand","given":"Markus A.","display":"Weigand, Markus A.","role":"aut"},{"given":"Bernhard","family":"Zwißler","role":"aut","display":"Zwißler, Bernhard"},{"family":"Dossow","given":"Vera von","display":"Dossow, Vera von","role":"aut"}],"language":["eng"],"note":["Gesehen am 04.04.2022"],"id":{"eki":["1797412035"],"doi":["10.3390/jcm11041121"]},"relHost":[{"recId":"718632478","title":[{"title_sort":"Journal of Clinical Medicine","title":"Journal of Clinical Medicine","subtitle":"open access journal"}],"pubHistory":["1.2012 -"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"MDPI","dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisherPlace":"Basel"}],"disp":"Early use of methylene blue in vasoplegic syndrome a 10-year propensity score matched cohort studyJournal of Clinical Medicine","part":{"pages":"1-12","volume":"11","extent":"12","year":"2022","text":"11(2022), 4, Artikel-ID 1121, Seite 1-12","issue":"4"},"note":["Gesehen am 12.06.20"],"id":{"eki":["718632478"],"zdb":["2662592-1"],"issn":["2077-0383"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"20 February 2022"}],"name":{"displayForm":["Othmar Kofler, Maximilian Simbeck, Roland Tomasi, Ludwig Christian Hinske, Laura Valentina Klotz, Florian Uhle, Frank Born, Maximilian Pichlmaier, Christian Hagl, Markus Alexander Weigand, Bernhard Zwißler and Vera von Dossow"]},"physDesc":[{"extent":"12 S."}],"title":[{"title_sort":"Early use of methylene blue in vasoplegic syndrome","title":"Early use of methylene blue in vasoplegic syndrome","subtitle":"a 10-year propensity score matched cohort study"}],"recId":"1797412035"} 
SRT |a KOFLEROTHMEARLYUSEOF2020